MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial

Cognitive-behavioural conjoint therapy (CBCT) for PTSD has been shown to improve PTSD, relationship adjustment, and the health and well-being of partners. MDMA (3,4-methylenedioxymethamphetamine) has been used to facilitate an individual therapy for PTSD. This study was an initial test of the safety...

Full description

Bibliographic Details
Main Authors: Candice M. Monson, Anne C. Wagner, Ann T. Mithoefer, Rachel E. Liebman, Allison A. Feduccia, Lisa Jerome, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin, Michael C. Mithoefer
Format: Article
Language:English
Published: Taylor & Francis Group 2020-12-01
Series:European Journal of Psychotraumatology
Subjects:
ptsd
treatment
cognitive-behavioural
conjoint
couple
therapy
mdma
Online Access:http://dx.doi.org/10.1080/20008198.2020.1840123

Internet

http://dx.doi.org/10.1080/20008198.2020.1840123

Similar Items